In our “HOT” stock column, Michael Gable, managing director of Fairmont Equities, explains why shares in Newmont (NEM) are a good buy right now, and should continue to head higher over time.

For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans explains why Morgans considers Resmed (RMD) to be an ADD to an investment portfolio.

Here are two situations where the odds might be on the side of the speculators! But always remember the risk.

It’s an interesting exercise to look at sectors dominated by a stock heavyweight, and search for value in peer stocks not attracting passive capital. The A-REIT sector is a good place to start. Here..

In our “HOT” stock column, Michael Gable, managing director of Fairmont Equities, explains why he’s still a buyer of PME for his clients.

In our HOT stock column today, Raymond Chan, Head of Asian Desk, explains why Morgans maintains its ADD rating for Mineral Resources Ltd (MIN).

The ASX has a burgeoning life sciences cohort doing great work in a range of major diseases. Here are four interesting cancer fighters.

Leading listed investment companies AFIC and Argo are trading at unusually large discounts to their net tangible assets (NTA).

In our “HOT” stock column, Michael Wayne, Managing Director of Medallion Financial Group, says that for investors who feared they may have missed their chance with Audinate, the current price may ..

For our “HOT” stock today, Raymond Chan, Head of Asian Desk at Morgans, looks at the good news associated with CSL.